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Recent review of Bidulescu and colleagues’
article on the association between vitamin
D and adiponectin and its relationship with
body mass index in African-Americans, as
compared to Whites, reinforced the value of
conducting stratified analyses using more
resolute subpopulation/subgroup data (1).
Although potential mechanisms were care-
fully considered and described by the inves-
tigators of the META-Health Study, the
mixed results raised questions about how
vitamin D and adiponectin interact in the
presence of normal weight versus obe-
sity. For example, the authors hypothe-
sized that the inverse association between
vitamin D and adiponectin among lean
African-American women may be due to
a possible reduced negative regulation of
the adipose-tissue renin-angiotensin sys-
tem by vitamin D metabolites. While this
explanation has some support in the liter-
ature (2, 3), the significant direct associa-
tion between vitamin D and adiponectin
among lean White women and the lack of
association found among obese individu-
als suggest biological pathways by which
vitamin D affects adiponectin expression
may be more complex in subgroups and
may require further characterization. Prior
studies have indicated that adiponectin
secretion is paradoxically decreased in obe-
sity, likely as a result of the inhibitory effects
of inflammatory factors secreted by hyper-
trophic adipocytes (i.e., as in obesity) (3–
5). Taken together, the results of the META-
Health Study suggest that further research
may be needed to characterize how vita-
min D actually mediate obesity and car-
diovascular risk through adiponectin lev-
els by race, gender, and body mass index
categories. As indicated by the authors,
these study data, in spite of their inher-
ent limitations, could be used to inform if
and how randomized controlled trials and
other studies on vitamin D supplementa-
tion should be conducted. An added value
of Bidulescu et al.’s investigation is the con-
tribution of mixed results to the evidence
base in this field. All too often, publication
bias impedes release of these kinds of null
or mixed result findings, especially as they
relate to subpopulations or subgroups with
high burden of obesity, diabetes, and/or
cardiovascular disease. In the “real” world
setting, e.g., in health policy and clini-
cal practice, negative or mixed results fre-
quently have as much of an impact as
positive results on decision-making.
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